#EAU18 #MedicalConference coverage w/ @tchandra_uromd :High Competing Risks Minimize Real-World Utility of Adjuvant Targeted Therapy in Renal Cell Carcinoma: A Population-Based Analysis #RCC coverage by: @tchandra_uromd https://t.co/LyiIkgsydQ https://t.co/oOUKczJG7z
#EAU18 #MedicalConference coverage w/ @tchandra_uromd :High Competing Risks Minimize Real-World Utility of Adjuvant Targeted Therapy in Renal Cell Carcinoma: A Population-Based Analysis #RCC
coverage by: @tchandra_uromd
https://t.co/LyiIkgsydQ https://t.co/oOUKczJG7z